These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22622488)

  • 1. Breakthrough pain in patients referred to pain clinics: the Italian pain network retrospective study.
    Gatti A; Mediati RD; Reale C; Cuomo A; Vellucci R; Russo G; Costantini A; Canneti A; Luzi M; Mammucari M; Sabato AF
    Adv Ther; 2012 May; 29(5):464-72. PubMed ID: 22622488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian Oncological Pain Survey (IOPS): a multicentre Italian study of breakthrough pain performed in different settings.
    Mercadante S; Lazzari M; Reale C; Cuomo A; Fusco F; Marchetti P; Mediati RD; Chiurazzi B; Ciuffedra L; Caraceni A; Iaffaioli V; Luzzani M; Micheletto G; Papa A; Raffaeli W; Valle A; Caruso M; Di Costanzo F; Pinato G; Nardi F; Barni S; Natoli S; Mammucari M; Sabato AF; Dauri M;
    Clin J Pain; 2015 Mar; 31(3):214-21. PubMed ID: 25654429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness and safety of OROS® hydromorphone in break-through cancer pain treatment: a multicenter, prospective, open-label study in Korean patients.
    Lee KH; Kim MK; Hyun MS; Kim JY; Park KU; Song HS; Lee SA; Lee WS; Bae SH; Ryoo HM; Cho YY
    J Opioid Manag; 2012; 8(4):243-52. PubMed ID: 22941852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of opioid rotation in the control of cancer pain: the ROTODOL study.
    González-Barboteo J; Alentorn XG; Manuel FA; Candel VA; Eito MA; Sánchez-Magro I; Álvarez MN; Martín FJ; Porta-Sales J
    J Opioid Manag; 2014; 10(6):395-403. PubMed ID: 25531957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS).
    Mercadante S; Marchetti P; Cuomo A; Caraceni A; Mediati RD; Mammucari M; Natoli S; Lazzari M; Dauri M; Airoldi M; Azzarello G; Bandera M; Blasi L; Cartenì G; Chiurazzi B; Costanzo BVP; Degiovanni D; Fusco F; Guardamagna V; Iaffaioli V; Liguori S; Lorusso V; Mameli S; Mattioli R; Mazzei T; Melotti RM; Menardo V; Miotti D; Moroso S; De Santis S; Orsetti R; Papa A; Ricci S; Sabato AF; Scelzi E; Sofia M; Tonini G; Aielli F; Valle A;
    Adv Ther; 2017 Jan; 34(1):120-135. PubMed ID: 27873235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose.
    Mercadante S; Ferrera P; Adile C; Casuccio A
    J Pain Symptom Manage; 2011 Sep; 42(3):464-9. PubMed ID: 21477977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of sublingual fentanyl for breakthrough pain by using doses proportional to opioid basal regimen.
    Mercadante S; Prestia G; Casuccio A
    Curr Med Res Opin; 2013 Nov; 29(11):1527-32. PubMed ID: 23869428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakthrough pain in opioid-treated chronic non-malignant pain patients referred to a multidisciplinary pain centre: a preliminary study.
    Højsted J; Nielsen PR; Eriksen J; Hansen OB; Sjøgren P
    Acta Anaesthesiol Scand; 2006 Nov; 50(10):1290-6. PubMed ID: 16999839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the traditional definition of breakthrough pain: an observational study.
    Gatti A; Gentili M; Iorno V; Mammucari M; Tufaro G; Lazzari M; Sabato AF
    Adv Ther; 2013 Mar; 30(3):298-305. PubMed ID: 23444055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian variation of breakthrough pain in cancer patients.
    Saini A; Tucci M; Tampellini M; Maina D; Bouraouia K; Giuliano PL; Termine A; Castellano M; Campagna S; Laciura P; Berruti A
    Eur J Pain; 2013 Feb; 17(2):264-70. PubMed ID: 22715071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Episodic (breakthrough) pain prevalence in a population of cancer pain patients. Comparison of clinical diagnoses with the QUDEI--Italian questionnaire for intense episodic pain.
    Caraceni A; Bertetto O; Labianca R; Maltoni M; Mercadante S; Varrassi G; Zaninetta G; Zucco F; Bagnasco M; Lanata L; De Conno F;
    J Pain Symptom Manage; 2012 May; 43(5):833-41. PubMed ID: 22560355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer.
    Portenoy RK; Taylor D; Messina J; Tremmel L
    Clin J Pain; 2006; 22(9):805-11. PubMed ID: 17057563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC, ACTIQ).
    Taylor DR; Webster LR; Chun SY; Reinking J; Stegman M; Shoemaker S; Fortner B
    Pain Med; 2007 Apr; 8(3):281-8. PubMed ID: 17371416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain.
    Sperlinga R; Campagna S; Berruti A; Laciura P; Ginosa I; Paoletti S; Giuliano PL; Tucci M; Rosato R; Scagliotti GV; Saini A
    Eur J Pain; 2015 Aug; 19(7):881-8. PubMed ID: 25370838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fentanyl buccal tablet on pain-related anxiety: a 4-week open-label study among opioid-tolerant patients with chronic and breakthrough pain.
    Webster LR; Messina J; Xie F; Nalamachu S
    J Opioid Manag; 2011; 7(4):297-308. PubMed ID: 21957829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective Observational Study on the Characteristics of Pain and Associated Factors of Breakthrough Pain in Advanced
    Fan R; Li X; Yang S; Bu X; Chen Y; Wang Y; Qiu C
    Pain Res Manag; 2022; 2022():8943292. PubMed ID: 35463627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study.
    Kurita GP; Sjøgren P; Ekholm O; Kaasa S; Loge JH; Poviloniene I; Klepstad P
    J Clin Oncol; 2011 Apr; 29(10):1297-303. PubMed ID: 21357785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough pain: progress in management.
    Lossignol DA; Dumitrescu C
    Curr Opin Oncol; 2010 Jul; 22(4):302-6. PubMed ID: 20489619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Movement-evoked breakthrough cancer pain despite intrathecal analgesia: a prospective series.
    Bäckryd E; Larsson B
    Acta Anaesthesiol Scand; 2011 Oct; 55(9):1139-46. PubMed ID: 22092213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.